Home » World News » Months of Trial and Error in the ICU Offer Clues on How to Save Covid Patients
Months of Trial and Error in the ICU Offer Clues on How to Save Covid Patients
Sanja Jelic’s worst day in almost two decades as a critical care doctor in New York City was April 6.
Faced with an unmanageable influx of coronavirus patients at Columbia University Irving Medical Center’s step-down unit, an intermediate care ward, Jelic made an unorthodox decision: she asked those struggling to breathe to roll onto their bellies while they waited for intubation to mechanically ventilate their inflamed lungs.
It wasn’t a random guess. Laying patients in the stomach-downprone position is known to improve oxygenation in sedated, intubated patients withacute respiratory distress syndrome. But there was no guarantee the same would hold true for wakeful Covid patients who were gasping for air.
“We had to buy time,” Jelic, who is also an associate professor of medicine at Columbia University, recalled in an interview. “I remember, the first three patients really had a dramatic improvement in their oxygenation.”
49,199 in U.S.Most new cases today
-7% Change in MSCI World Index of global stocks since Wuhan lockdown, Jan. 23
-1.038 Change in U.S. treasury bond yield since Wuhan lockdown, Jan. 23
-2.3% Global GDP Tracker (annualized), May
Bloomberg QuickTake@QuickTakeCould lying on their stomachs help #Covid19 patients? @ColumbiaMed's Dr. Sanja Jelic says proning, or lying on one's tummy, could increase oxygenation, which could aid #coronavirus victims8:24 AM · Jun 24, 202037See the latest COVID-19 information on Twitter
In the absence of a cure, doctors like Jelic were left relying in part on trial and error, but months into the most destructive pandemic in a century, their collective experience is starting to build a framework of how best to cope with coronavirus patients.
As many as 1,000 Covid-related research papers are being released daily ahead of peer review and publication, according toSoumya Swaminathan, the World Health Organization’s chief scientist. “Our goal is to see that the learnings from science are as quickly as possible channeled into impacts for patients and communities,” shetold reporters in Geneva on Thursday.
‘How You Do It’
The collective experience may be showing results. U.S. deaths, which often ranged between 2,000 and 3,000 a day in April and May, have mostly remained below 1,000 and in the low hundreds since the beginning of June.
The WHO is collating data from countries to identify crucial elements that reduce mortality. These include how health systems triage Covid-19 patients, how they protect those vulnerable to more serious complications, and the speed with which they provide intensive care.
The goal is to create a tool box that will enable doctors to provide better care for the full range of patients with Covid-19, which has turned out to be more than just a respiratory disease, saidSylvie Briand, the WHO’s director for global infectious hazard preparedness.
“It’s not only what you do -- sometimes at this level there is no difference -- but it’s how you do it,” Briand said in an interview.
Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, also credits better experience with medicines.
“Whenever you’re in an outbreak, there are two things about treatment that contribute to improvement,” he said. “Not only do you get better in practice, but you get better because of new treatments.”
In April,Gilead Sciences Inc.’s antiviral remdesivir, now approved with the brand name Veklury, was shown to speedrecovery time. Last month, the inexpensive corticosteroiddexamethasone was found to reduce deaths by one-third among patients receiving mechanical ventilation. Doctors are also routinely administering heparin and other anticoagulants to prevent dangerous blood clots from forming in the veins of the critically ill.
Read More:Coronavirus Causes Damaging Blood Clots From Brain to Toes
Although the “awake proning” approach Jelic and colleagues tried hasn’t been properly studied yet in a large clinical trial, it points to a cheap and simple way overwhelmed health centers may be able to help severely ill patients. Their research, published in a June 17letter to the Journal of the American Medical Association, indicated that it reduced the probability patients would need intubation. The journal also published an invitedcommentary subtitled “necessity is the mother of invention.”
“I couldn’t agree more with the title,” Jelic said. “I have never seen this much strain on our ICU resources.”
Laying on the stomach improves blood circulation in the upper portion of the lung, she said, increasing the volume of oxygen and carbon dioxide that can be exchanged. It also decreases pressure around the lung, and can help clear secretions from the airways, studies show.
While combination treatments -- the HIV medications ritonavir and lopinavir, and the antimalarial drugs hydroxychloroquine and chloroquine with the antibiotic azithromycin --failed to reduce death in hospitalized Covid-19 patients, there’s optimism for others. These include antibody-based therapies andblood products from survivors.
The antiflammatory infusioninfliximab, sold by Johnson & Johnson and Merck & Co. as Remicade, is being studied by Tufts Medical Center in Boston as a way of circumventing the major cause of lethal complications in a subset of Covid-19 patients: A damaging immune response, sometimes referred to as acytokine storm, that usually occurs in the second week of illness.
Read More:Coronavirus Nears Fatal ‘Tipping Point’ When Lungs Inflamed
Infliximab blocks tumor necrosis factor-alpha, a cell-signaling protein or “cytokine” that plays a key role in driving the immune system to exhaustion in response to infections, saidPaul Mathew, a cancer specialist at Tufts University School of Medicine who’s leading the study. The medicine may also help avert life-threatening blood-clotting problems that can occur in Covid patients.
"It's much more complex." Dr. @SCBriand@WHO says there’s no magic, life-saving “bullet” when it comes to #Covid1910:56 AM · Jun 30, 2020
See the latest COVID-19 information on Twitter
“Little by little, we discovered new signs and symptoms of the disease,” said the WHO’s Briand. “Now we know that there is really a lot of possibilities for this virus to attack the human body.”
Read More:All the Covid-19 Symptoms You Didn’t Know About
These range from a suddenlack of smell to a multi-system inflammatory syndrome inchildren -- features that have become more apparent with more than 11 million Covid cases worldwide. Others include clotting-related disorders that can be benign skin lesions on the feet, sometimes called “Covid toe,” or potentially lethal strokes.
The more Covid patientsJarrod Mosier sees in his hospital’s intensive care unit in Tucson, Arizona, the more he says he’s convinced that saving lives comes down to protecting the lungs of those with acute respiratory distress syndrome, or ARDS, caused by pulmonary inflammation. Most patients need breathing support, but too little or too much air pressure and volume can damage the lungs further.
“I look at all of those things and tinker with the ventilator for a good while everyday to try to find that balance,” Mosier said. “To me, that is the thing that will save the most lives in this disease -- just excellent critical care management of ARDS.”
Mosier said he’s hoping it results in better patient survival. “I think that’s the case, but it’s very hard to answer that question when you’re in the thick of it,” he said. “Some days I think we’re actually getting pretty good at this. And other days I think, ‘This is demoralizing.’”